Skip to content
Brand AI

Wandong

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2018

    Wandong Medical then-chairman Wu Guangming publicly censured for short-swing trading; M&A involved insider trading

    Wu Guangming, then chairman of Wandong Medical and actual controller of Yuyue Medical, engaged in short-swing trading in the company's shares; he was publicly censured by the Shanghai Stock Exchange and deemed unsuitable to serve as a director, supervisor or senior executive of a listed company for three years. In a major asset transaction related to Wandong, Qian Bao and Zhang Jiaqi used inside information to trade its shares. In 2023, the Hunan Securities Regulatory Bureau confiscated illegal gains of 416,200 yuan and 192,200 yuan from Qian Bao and Zhang Jiaqi, respectively, and fined each 500,000 yuan.

    Source